Literature DB >> 34661145

Don't Compromise Myeloma Care Due to COVID-19 Pandemic!

Nikhil C Munshi1,2, Kenneth C Anderson1.   

Abstract

Patients with active myeloma, especially with earlier stages of the disease, are susceptible to COVID-19 infection and can have adverse outcomes, even in those on first-line treatment. Importantly, myeloma therapy can be safely administered, and optimal control of myeloma is associated with improved outcome. See related video: https://vimeo.com/486246183/559a80cfae See related article by Hultcrantz et al., p. 234. ©2020 American Association for Cancer Research.

Entities:  

Mesh：

Year:  2020        PMID： 34661145      PMCID： PMC8504755          DOI： 10.1158/2643-3230.BCD-20-0151

Source DB:  PubMed          Journal:  Blood Cancer Discov        ISSN： 2643-3230


  6 in total

1.  With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study.

Authors:  Nathanael R Fillmore; Sarvari V Yellapragada; Chizoba Ifeorah; Ansh Mehta; Diana Cirstea; Paul S White; Gustavo Rivero; Andrew Zimolzak; Saiju Pyarajan; Nhan Do; Mary Brophy; Nikhil C Munshi
Journal:  Blood       Date:  2019-04-19       Impact factor: 22.113

2.  Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality.

Authors:  Joaquín Martínez-López; María-Victoria Mateos; Cristina Encinas; Anna Sureda; José Ángel Hernández-Rivas; Ana Lopez de la Guía; Diego Conde; Isabel Krsnik; Elena Prieto; Rosalía Riaza Grau; Mercedes Gironella; María Jesús Blanchard; Nerea Caminos; Carlos Fernández de Larrea; María Alicia Senin; Fernando Escalante; José Enrique de la Puerta; Eugenio Giménez; Pilar Martínez-Barranco; Juan José Mateos; Luis Felipe Casado; Joan Bladé; Juan José Lahuerta; Javier de la Cruz; Jesús San-Miguel
Journal:  Blood Cancer J       Date:  2020-10-19       Impact factor: 11.037

3.  Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy.

Authors:  Gordon Cook; A John Ashcroft; Guy Pratt; Rakesh Popat; Karthik Ramasamy; Martin Kaiser; Matthew Jenner; Sarah Henshaw; Rachel Hall; Jonathan Sive; Simon Stern; Matthew Streetly; Ceri Bygrave; Richard Soutar; Neil Rabin; Graham H Jackson
Journal:  Br J Haematol       Date:  2020-06-10       Impact factor: 8.615

4.  Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.

Authors:  David J Pinato; Alberto Zambelli; Juan Aguilar-Company; Mark Bower; Christopher Sng; Ramon Salazar; Alexia Bertuzzi; Joan Brunet; Ricard Mesia; Elia Segui; Federica Biello; Daniele Generali; Salvatore Grisanti; Gianpiero Rizzo; Michela Libertini; Antonio Maconi; Nadia Harbeck; Bruno Vincenzi; Rossella Bertulli; Diego Ottaviani; Anna Carbo; Riccardo Bruna; Sarah Benafif; Andrea Marrari; Rachel Wuerstlein; M Carmen Carmona-Garcia; Neha Chopra; Carlo Tondini; Oriol Mirallas; Valeria Tovazzi; Marta Betti; Salvatore Provenzano; Vittoria Fotia; Claudia Andrea Cruz; Alessia Dalla Pria; Francesca D'Avanzo; Joanne S Evans; Nadia Saoudi-Gonzalez; Eudald Felip; Myria Galazi; Isabel Garcia-Fructuoso; Alvin J X Lee; Thomas Newsom-Davis; Andrea Patriarca; David Garcia-Illescas; Roxana Reyes; Palma Dileo; Rachel Sharkey; Yien Ning Sophia Wong; Daniela Ferrante; Javier Marco-Hernandez; Anna Sureda; Clara Maluquer; Isabel Ruiz-Camps; Gianluca Gaidano; Lorenza Rimassa; Lorenzo Chiudinelli; Macarena Izuzquiza; Alba Cabirta; Michela Franchi; Armando Santoro; Aleix Prat; Josep Tabernero; Alessandra Gennari
Journal:  Cancer Discov       Date:  2020-07-31       Impact factor: 39.397

5.  Clinical Characteristics of Covid-19 in New York City.

Authors:  Parag Goyal; Justin J Choi; Laura C Pinheiro; Edward J Schenck; Ruijun Chen; Assem Jabri; Michael J Satlin; Thomas R Campion; Musarrat Nahid; Joanna B Ringel; Katherine L Hoffman; Mark N Alshak; Han A Li; Graham T Wehmeyer; Mangala Rajan; Evgeniya Reshetnyak; Nathaniel Hupert; Evelyn M Horn; Fernando J Martinez; Roy M Gulick; Monika M Safford
Journal:  N Engl J Med       Date:  2020-04-17       Impact factor: 176.079

6.  Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.

Authors:  Donna R Rivera; Solange Peters; Yu Shyr; Gary H Lyman; Jeremy L Warner; Orestis A Panagiotou; Dimpy P Shah; Nicole M Kuderer; Chih-Yuan Hsu; Samuel M Rubinstein; Brendan J Lee; Toni K Choueiri; Gilberto de Lima Lopes; Petros Grivas; Corrie A Painter; Brian I Rini; Michael A Thompson; Jonathan Arcobello; Ziad Bakouny; Deborah B Doroshow; Pamela C Egan; Dimitrios Farmakiotis; Leslie A Fecher; Christopher R Friese; Matthew D Galsky; Sanjay Goel; Shilpa Gupta; Thorvardur R Halfdanarson; Balazs Halmos; Jessica E Hawley; Ali Raza Khaki; Christopher A Lemmon; Sanjay Mishra; Adam J Olszewski; Nathan A Pennell; Matthew M Puc; Sanjay G Revankar; Lidia Schapira; Andrew Schmidt; Gary K Schwartz; Sumit A Shah; Julie T Wu; Zhuoer Xie; Albert C Yeh; Huili Zhu
Journal:  Cancer Discov       Date:  2020-07-22       Impact factor: 38.272
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.